Biocryst Pharmaceuticals reported $34.99M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Chemocentryx CCXI:US $ 19.6M 100K
Chugai Pharma 4519:JP 24.71B 1.63B
Daiichi Sankyo 4568:JP 84.5B 5.38B
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Glaxosmithkline GSK:US 2.5B 6M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novavax NVAX:US $ 77.79M 4.63M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
YTE INCY:US $ 190.7M 21.84M
Zogenix ZGNX:US $ 39.56M 5.68M